Socrates E. Papapoulos

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

Elizabeth Shane, David B. Burr, Peter R. Ebeling et al. · Journal of Bone and Mineral Research · 2010 · 1.1K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Kenneth Poole, Rutger L. van Bezooijen, N. Loveridge et al. · The FASEB Journal · 2005 · 962 citations

Medicine, Oral Biology, Bone Metabolism +16

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi et al. · The Lancet Diabetes & Endocrinology · 2017 · 961 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist

Rutger L. van Bezooijen, Bernard A.J. Roelen, Annemieke Visser et al. · The Journal of Experimental Medicine · 2004 · 883 citations · Full text

Medicine, Biochemistry, Molecular Biology +15

Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis

Harry K. Genant, Cyrus Cooper, Gyula Poór et al. · Osteoporosis International · 1999 · 786 citations

Medicine, Orthopedic Surgery, Preventive Medicine +14